The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Hadji, Peyman

Stoetzer, Oliver

Decker, Thomas

Kurbacher, Christian M.

Marme, Frederik

et al.

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Published in

Journal of Bone Oncology ; 14 (2019). - Art.-Nr. UNSP 100199. - ISSN 2212-1374

Link to publication

https://dx.doi.org/10.1016/j.jbo.2018.09.010

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record